When researchers discovered a weed toxic to sheep showed promise against a rare genetic condition, Gorlin syndrome, a pharmaceutical company jumped to test it. 

The town of Reserve, Louisiana has 50X higher cancer risk than the US national average. No household is untouched by the disease, and this Guardian series—Cancer Town—tracks residents’ quest for clean air in “Cancer Alley,” which sits between New Orleans and Baton Rouge.  …

After being diagnosed with acute myeloid leukemia, Astrid’s success with chemotherapy was short-lived. When stem cell donations became her last hope, she discovered a shocking ethnic disparity in the global pool of donated stem cells, the mother of 2 writes. Stem cells are…

How serious is the threat to sub-Saharan Africa posed by noncommunicable diseases? Consider 2 new findings by Hebe N. Gouda, University of Queensland, and colleagues in the Lancet Global Health. Using data from 1990 to 2017, they found:

Cancer, now the leading killer in wealthy countries, is on track to outpace cardiovascular disease as the leading cause of death globally in the next few decades, according to research published yesterday in the Lancet.  

From 2008-2018, a third of clinical trials that produced new cancer drugs failed to report the race of participants.A new study also found that even among trials that did, participation numbers were not representative of the general cancer patient population: just 6%…

It seems logical that large, long-living mammals would be more prone to cancer—they have more cells and more opportunities for dangerous mutations. But in a “quirk of nature” they actually die of cancer less frequently than their smaller cousins.

US sanctions on Iran are hitting hard for terminally ill patients like Parsa, a 5-year-old in Tehran with liver cancer. The country’s economy is in free fall after a landmark deal to lift sanctions in exchange for rollbacks to Iran’s nuclear program collapsed. The US claims…

The yawning gap in child cancer survival between wealthy and poorer countries is fueled by a perception that treatment is too costly and complicated for low-resource settings.   North American children with cancer now have a 5-year survival rate of 80%—while more than 80%…

Africa is home to the most genetically diverse population in the world. Yet just 2% of genetic materials used in pharmaceutical research comes from the continent; 90% comes from Caucasians.   Abasi Ene-Obong is looking to change that with 54gene, the first biobank of…